Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Young Adults with Ewing Sarcoma.
This record reports a phase II clinical study of allogeneic hematopoietic stem cell transplantation in children and young adults with Ewing sarcoma, apparently in the relapsed or refractory setting.
Open original publication →What the AI sees
This record reports a phase II clinical study of allogeneic hematopoietic stem cell transplantation in children and young adults with Ewing sarcoma, apparently in the relapsed or refractory setting.
Research significance
The study directly evaluates allogeneic transplantation as a treatment strategy; based only on the title and keywords, a possible graft-versus-tumor effect is the inferred therapeutic rationale, but no efficacy, safety, or mechanistic results are supplied.
Source abstract
No abstract available.